Novartis AG vs Zoom Video Communications, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Zoom Video Communications, Inc. trades at $89.52 (market cap $26.66B). The key difference: Novartis AG is far larger — about 10.9× Zoom Video Communications, Inc.'s market cap, and Novartis AG pays a 3.17% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| NVS | ZM | |
|---|---|---|
Market Cap | $290.25B | $26.66B |
Sector | Health | Technology |
52-Week High | $168.62 | $111.88 |
52-Week Low | $113.50 | $69.77 |
Enterprise Value | $330.27B | $19.00B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →